Valuation Merck & Co., Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 15:15:32 10/02/2026 GMT			5-day change	1st Jan Change
116.76 ^USD	-0.76%		+0.82%	+10.96%

11:52am	Rothschild & Co Redburn Adjusts Price Target on Merck & Co. to $140 From $135, Maintains Buy Rating	MT
11:06am	Calla Lily Clinical Care and Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	206,957	193,588	281,302	276,259	251,648	292,010	292,010	-
Change	-	-6.46%	45.31%	-1.79%	-8.91%	16.04%	0%	-
Enterprise Value (EV) ¹	230,686	218,594	298,801	304,221	275,517	316,351	321,238	310,962
Change	-	-5.24%	36.69%	1.81%	-9.44%	14.82%	1.55%	-3.2%
P/E ratio	29.4x	14.9x	19.4x	779x	14.8x	14.5x	26.7x	13.5x
PBR	8.18x	5.07x	6.12x	7.34x	5.44x	5.3x	5.55x	4.19x
PEG	-	0.2x	1.7x	-8x	0x	1.81x	-0.6x	0.1x
Capitalization / Revenue	4.31x	3.97x	4.75x	4.6x	3.92x	4.02x	4.38x	4.15x
EV / Revenue	4.81x	4.49x	5.04x	5.06x	4.29x	4.88x	4.82x	4.41x
EV / EBITDA	11.2x	10.5x	11.3x	30.2x	9.88x	10.7x	15.3x	9.74x
EV / EBIT	13.6x	12.4x	13.3x	49x	11.8x	11.8x	17.9x	10.6x
EV / FCF	41.4x	25.2x	20.3x	33.3x	15.2x	14.7x	21.8x	12.8x
FCF Yield	2.41%	3.97%	4.92%	3.01%	6.57%	6.79%	4.59%	7.82%
Dividend per Share ²	2.48	2.64	2.8	2.96	3.12	3.229	3.369	3.535
Rate of return	3.03%	3.44%	2.52%	2.72%	3.14%	2.74%	2.86%	3%
EPS ²	2.78	5.14	5.71	0.14	6.74	7.28	4.41	8.706
Distribution rate	89.2%	51.4%	49%	2,114%	46.3%	41.7%	76.4%	40.6%
Net sales ¹	47,994	48,704	59,283	60,115	64,168	65,011	66,702	70,434
EBITDA ¹	20,570	20,910	26,431	10,083	27,897	29,685	20,986	31,919
EBIT ¹	16,945	17,696	22,522	6,211	23,398	26,779	17,942	29,258
Net income ¹	7,067	13,049	14,519	365	17,117	18,254	10,856	21,165
Net Debt ¹	23,729	25,006	17,499	27,962	23,869	24,341	29,228	18,952
Reference price ²	81.80	76.64	110.95	109.02	99.48	117.65	117.65	117.65
Nbr of stocks (in thousands)	2,530,034	2,525,944	2,535,396	2,534,023	2,529,636	2,482,023	2,482,023	-
Announcement Date	04/02/21	03/02/22	02/02/23	01/02/24	04/02/25	03/02/26	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
MERCK & CO., INC.	15.19x	4.88x	10.66x	2.74%	292B
ELI LILLY AND COMPANY	46.33x	15.08x	33.42x	0.56%	935B
JOHNSON & JOHNSON	21.68x	6.39x	17.77x	2.16%	575B
ABBVIE INC.	62.34x	7.4x	18.33x	2.93%	395B
ROCHE HOLDING AG	18.31x	4.61x	11.46x	2.84%	368B
ASTRAZENECA PLC	29.93x	5.39x	16.08x	1.71%	294B
NOVARTIS AG	20.59x	5.81x	14.18x	2.94%	299B
NOVO NORDISK A/S	14.8x	5.06x	10.73x	3.46%	220B
AMGEN INC.	29.2x	6.79x	11.63x	2.54%	202B
GILEAD SCIENCES, INC.	22.25x	6.89x	12.59x	2.19%	188B
Average	28.06x	6.83x	15.69x	2.41%	376.85B
Weighted average by Cap.	31.81x	8.21x	19.13x	2.08%